Surgery In Diabetes Mellitus (DM)

Slides:



Advertisements
Similar presentations
Diabetic Ketoacidosis in Children
Advertisements

Emergency Care Part 1: Managing Diabetic Ketoacidosis (DKA)
Presentation title Emergency Care Part 3: Surgery in Children with Diabetes.
Prescribing IV Infusions
0 - 0.
Joanna Prickett North Bristol NHS Trust
Inpatient Hyperglycemia Management
Advanced Pumping. Objectives: Identify situations to utilize temporary basal rate in pump therapy patients. Identify examples of when to use combination.
Blood glucose monitoring
Fluid, Electrolyte, and Acid-Base Imbalances
Dr. Amel F. Al-Sayed Asst. Prof. & Consultant Department of Obstetrics & Gynecology.
Diabetes in Schools Reviewing the New Laws Diane Stewart APN-C, CDE.
Long-term Complications of Type 2 Diabetes
Test B, 100 Subtraction Facts
Management of Diabetic Ketoacidosis in the PICU
Susan Alexander, DNP, CNS, CRNP, BC- ADM College of Nursing University of Alabama in Huntsville Clinical Affiliation: Outpatient Diabetes Self-Management.
In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Block 9 Board Review Endocrine/Rheum 14Feb14 Chauncey D. Tarrant, M.D. Chief of Residents
Diabetic keto-acidosis (DKA) DKA or Hyperglycemia coma is defined when blood sugar mg/dl Is primarily seen in I.D.DM - can be seen in NIDDM. DKA.
Hyperglycaemia Diabetes Outreach (August 2011). 2 Hyperglycaemia Learning objectives >Can state what hyperglycaemia is >Is aware of the short term and.
Canadian Diabetes Association Clinical Practice Guidelines In-Hospital Management of Diabetes Chapter 16 Robyn Houlden, Sara Capes, Maureen Clement, David.
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
Islets of Langerhan. Prof. K. Sivapalan Islets of Langerhan2 Histology. A cells 20 % [glucogon] B cells 50% [Insulin] D cells 8% [somatostatin]
Diabetes Mellitus.
Metabolic complications of Diabetes Mellitus
Hypoglycemia Paolo Aquino 29 January Overview of hypoglycemia  What is it?  Why do we care about it?  What causes it?  How do we diagnose it?
Oral Glucose Tolerance Test By: Dr. Beenish Zaki Date: 09/05/2012 Senior Instructor Department of Biochemistry.
Perioperative Diabetes Management Dr. Ken Locke March 2007.
Diabetes Mellitus and the Surgical Patient Dr. Cathy Code Division of General Internal Medicine.
Diabetes Mellitus Diabetes Mellitus is a group of metabolic diseases characterized by elevated levels of glucose in blood (hyperglycemia) Diabetes Mellitus.
Diabetes Mellitus Type 1
Case 6 A 54 year old obese person come in emergency with altered consciousness level and increase respiratory rate (tachypnia) for last 4 hours. He is.
Diabetic Ketoacidosis DKA)
DIABETES AND HYPOGLYCEMIA. What is Diabetes Mellitus? “STARVATION IN A SEA OF PLENTY”
ACUTE COMPLICATIONS. 18 years old diabetic patient was found to be in coma What questions need to be asked ? Differentiating hypo from hyperglycemia ?
Nutrition and Metabolism Negative Feedback System Pancreas: Hormones in Balance Insulin & Glucagon Hormones that affect the level of sugar in the blood.
5/26/2016 8:44 AM Reviewing Carbohydrates. 5/26/2016 8:44 AM Functions of Carbohydrates Why do we need them? Provide Energy Spare Protein Promote Normal.
Pancreas Pancreas is a glandular organ located beneath the stomach in the abdominal cavity. Connected to the small intestine at the duodenum. Functions.
Hormones and the Endocrine System Chapter 45. ENDOCRINE SYSTEM Endocrine system – chemical signaling by hormones Endocrine glands – hormone secreting.
DIABETIC KETOACIDOSIS By, Dr. ASWIN ASOK CHERIYAN Chair Person – Dr. JAYAMOHAN A.S.
Management of diabetic ketoacidosis Prof. M.Alhummayyd.
DR. OLASOPE A.C REGISTRAR ENDOCRINOLOGY UNIT.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
Management of diabetic ketoacidosis (DKA) Prof. M.Alhummayyd.
Endocrine and Metabolic Disorders Lectures 8 I.Kuziv, MD, PhD.
PERI OPERATIVE DIABETES MANAGEMENT GUIDELINES AUSTRALIAN DIABETES SOCIETY.
Diabetic Ketoacidosis DKA PHCL 442 Lab Discussion 6 Raniah Al-Jaizani M.Sc.
Hypertension&Diabetes In surgery In surgery. Presented by: Dr. Saifuddin Ahmed Dr. Saifuddin Ahmed. Dr. Sammya Das Gupta Dr. Sammya Das Gupta.
Endocrine System KNH 411. Diabetes Mellitus 7% of population; 1/3 undiagnosed $132 billion in health care Sixth leading cause of death Complications of.
ADDITIONAL SLIDES FOR ASSIST WITH COMPREHENSION OF LAB CONTENT-MODULE FIVE-DM DENISE TURNER, MS-N.ED, RN, CCRN.
Diabetes, Surgery and GKI’s Maureen Wallymahmed Nurse Consultant - Diabetes.
Dr : Reem Murad. Sick days " refer to periods of minor intercurrent illness that require changes to the person's usual self management practices.
 Insulin is a peptide hormone released by beta cells when glucose concentrations exceed normal levels (70–110 mg/dL).  The effects of insulin on its.
Special Situations In The Management Of In-Patient Hyperglycemia
DIABETES MELLITUS. Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. DM is associated.
بايو كمستري (م 3) / د . احمد الطويل
GLUCOSE TOLERANCE TEST (GTT)
Diabetes Mellitus Nursing Management.
Emergency Care Part 3: Surgery in Children with Diabetes
ACUTE COMPLICATIONS.
ACUTE COMPLICATIONS.
Pregestational and gestational diabetes
Management of diabetic ketoacidosis
Metabolic Changes in Diabetes Mellitus
Insulin: understanding its action in health and disease
Obstetric Cholestasis (lntrahepatic cholestasis of pregnancy):
Emergency Care Part 3: Surgery in Children with Diabetes
Endocrine Emergencies
Inpatient Insulin Management on the Wards
Presentation transcript:

Surgery In Diabetes Mellitus (DM) Walid Sayed Abdelkader Hassanen Specialist of internal Medicine March 2010

Surgery In Diabetes Mellitus Hyperglycemia leads to impaired wound healing , deficient formation of granulation tissue. The chemotactic , phagocytic, and bacterial activity of the neutrophil is deficient , there is impaired hormonal host defense mechanism and abnormal complement function.

Metabolic sequelae in a surgical patient Increased glycogenolysis Increased gluconeogenesis hyperglycemia Decreased glucose utilization: Lipolysis with increased FFA Protein breakdown Increased nitrogen loss Increased urea production Increased sodium retension & potassium execretion and alteration of water metabolism ( increased ADH and increased aldosterone secretion ) free fatty acid (FFA) Antidiuretic hormone (ADH)

Determinents of the management plan Type of DM Treatment, diet, oral antidiabetic drugs, insulin Metabolic status Vascular status: cardiac, renal, cerebral Surgery: Type: emergency or elective Minor or major procedure Type of anesthesia Post operative oral intake

Pre-operative management Metabolic stress of surgery and anesthesia cause increased elaboration of catecholamins, glucocorticoids, glucagon, and growth hormone, all producing their metabolic effects resulting in hyperglycemia in the pre-operative period. The glycemic control is aimed to achieve a fasting plasma glucose of < 140 mg % and post prandial plasma glucose of < 200 mg %. Insulin dependent diabetic patients can be admitted 2-3 days prior to surgery to achieve satisfactory control.

Cont. In NIDDM patients if the control is good with oral antidiabetic drugs , these drugs are stopped on the day of the surgery and intravenous fluids and insulin are given , if not are advised to stop drugs one week before surgery and admitted for insulin therapy. NIDDM - noninsulin-dependent diabetes mellitus

Subcutaneous insulin therapy after admission When the fasting plasma glucose is 140 mg % to give 4 units of soluble insulin subcutaneously before breakfast and then monitor before lunch blood sugar , if the pre- lunch blood sugar is around 140 mg % it is advisable to give the same 4 units soluble insulin pre- meal. For every 40 mg rise in pre- meal blood sugar , pre-meal one unit of soluble insulin is added to the previous dose of pre-meal insulin If the blood sugar level is more than 300 mg % 15 units of soluble insulin pre-meal three times a day is tried.

Practical aspects In a few diabetics it is difficult to control fasting plasma glucose with pre-meal bolus soluble insulin, this situation requires addition of small dose of intermediate acting insulin at bed time. In a few NIDDM patients the blood sugar can not be controlled only with insulin, adding small doses of oral antidiabetic drug is rationale as this overcomes the resistance, on the day of surgery oral drugs are stopped.

On the day of surgery It is preferable to take diabetic patients for surgery in the morning as first case. Normally the requirement of insulin is 0.3 U to metabolize 1gm of glucose. When FPG < 120 mg % no insulin is given except 5% glucose. When FPG 120- 160 mg % 5 % glucose with 5 units soluble insulin. For FPG 160- 200 mg % 5 % glucose with 8 U of soluble insulin. FPG - fasting plasma glucose

Cont. If FPG crosses 200 and < 250 mg % 5 % glucose with 10 U of soluble insulin. Values between 250- 300 mg % to give normal saline with 6-8 U . If the blood sugar > 300 mg % 8-10 U are added to normal saline and surgery is delayed for few hours till satisfactory glycemic control is achieved. All the above infusions are given at the rate of 100-120 ml / h .

Post operative management With the resumption of oral feeds subcutaneous insulin can be started, NIDDM patients can resume their oral antidiabetic drugs after week if there is no complications of surgery.

Intravenous fluids Dextrose saline / normal saline is used if blood pressure is low or normal. If there is hypertension half normal saline or 5 % dextrose is given. For normal metabolism 50 gm glucose is required every 8 hours for energy and to avoid ketosis, to meet this demand at least 1000 cc 5 % glucose every 8 h will be required. In situations requiring fluid restriction 10 % dextrose can be infused instead of 5 % with double the dose of insulin.

Practical aspects Whatever is the pattern of infusion, the blood sugar has to be checked every tow hours and the flow rate is adjusted. Intra and post operative potassium monitoring is done and corrected appropriately. A few hours after surgery there will be reduction in the insulin requirement as the elevated counter hormones due to surgical stress decline.

Emergency surgery In emergency surgery it is deal to use intravenous insulin infusion.

Minor surgery For minor surgery the antidiabetic drugs and insulin are stopped on the day of surgery, once the surgery is over and the patient is permitted to resume oral feeds the antidiabetic drugs are started with half the dose which the patient was originally taking, on the second post operative day full dose of the oral drugs and or insulin are started.

Special situations Blood sugar may rapidly fall after surgical drainage of an infected area. Type 2 diabetes can be safely switched over to oral drugs after a week. In coronary artery bypass surgery and during and after renal transplantation the insulin requirements will be exceptionally high.

Our aim To make patients safe for surgery, for this we need an understanding team work between the surgeon, anesthetist and diabetologist. When the patient is under anesthesia the ideal is to have diabetic therapy supervised by a diabetic team where available.

THANK YOU